The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 13.26 EUR in weekly data.
The stock, which is currently worth 2019 to 0.33 times its sales, is clearly overvalued in comparison with peers.
Its low valuation, with P/E ratio at 8.15 and 4.83 for the ongoing fiscal year and 2020 respectively, makes the stock pretty attractive with regard to earnings multiples.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company does not generate enough profits, which is an alarming weak point.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The company's earnings releases usually do not meet expectations.
The company is not the most generous with respect to shareholders' compensation.
For the past seven days, analysts have been lowering their EPS expectations for the company.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Below the resistance at 19.25 EUR, the stock shows a negative configuration when looking looking at the weekly chart.